This is the one company that could leap frog right over us in a heartbeat. Their diabetic foot trial has most if not all outcome measures we do, and are expecting phase 2 results in November. Then who knows what the FDA could grant them. It is, a serious disease after all, that meets an unmet need.
Would sure make the two year delay by Zami to build out manufacturing, a momentous gaff on his part. Time will tell.